Cargando…
Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion
In this era of immune checkpoint inhibitors, inflammatory adverse events of anti-cancer therapies continue to pose a major challenge. Glucocorticoids, as the mainstay, were limited by serious side effects. Glucocorticoids induce myeloid-derived suppressor cells (MDSCs), and lactoferrin-induced polym...
Autores principales: | Li, Xing, Chen, Jie, Chen, Yong-Jian, Qiao, Yi-Dan, Zhao, Li-Yun, Jiang, Nan, Wu, Xiang-Yuan, Xing, Yan-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910613/ https://www.ncbi.nlm.nih.gov/pubmed/33637832 http://dx.doi.org/10.1038/s42003-021-01769-z |
Ejemplares similares
-
mTOR Signaling Regulates the Development and Therapeutic Efficacy of PMN-MDSCs in Acute GVHD
por: Li, Xiaoqing, et al.
Publicado: (2021) -
Accumulation of LOX-1(+) PMN-MDSCs in nasopharyngeal carcinoma survivors with chronic hepatitis B might permit immune tolerance to epstein–barr virus and relate to tumor recurrence
por: Li, Xing, et al.
Publicado: (2020) -
Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs
por: Mastio, Jérôme, et al.
Publicado: (2019) -
ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer
por: Chen, Huanhuan, et al.
Publicado: (2023) -
Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice
por: Kawano, Tomohiro, et al.
Publicado: (2019)